Xevant

Xevant's journey began with a challenge faced by its co-founder and CEO, Brandon Newman, during his time managing a small consulting firm. Struggling with the effective management of healthcare costs due to a lack of adequate resources, the seed for Xevant was planted. This initial hurdle spurred the development of an internal tool designed to simplify the complex data analysis inherent in healthcare management. Over time, this tool underwent significant evolution, blossoming into the cutting-edge data analytics platform known today as Xevant. Founded in 2017, Xevant was established to revolutionize healthcare management, with a particular focus on optimizing processes for those managing pharmacy benefits.

The company's mission from the outset has been to achieve the lowest net healthcare cost through intelligent, real-time, automated technology. This vision resonated with investors, leading to successful funding rounds that have propelled Xevant's growth and market penetration. Xevant's core offering is an innovative platform that streamlines the analysis of healthcare data, providing real-time insights and actionable solutions. This not only saves time but also aims to improve patient outcomes and facilitate immediate financial savings. Since its inception, Xevant has been committed to integrating artificial intelligence and automation into its services, a strategy that has enhanced efficiency and decision-making capabilities, keeping the company at the forefront of the dynamic healthcare market. The company has celebrated numerous milestones, including the launch of BidLogic in 2018, the release of its first fully integrated end-to-end solution (X3) in 2019, and the introduction of RebateLogic in 2022, continuously expanding its capabilities to meet the evolving needs of the pharmacy benefits industry. Xevant's commitment to innovation and its impact on the market have been recognized through various accolades, including rankings on the Inc. 5000 and Utah's fastest-growing companies lists.